Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/35667
Title: | Calcium vs. Pentagastrin Stimulation bei der C-Zell-Erkrankung der Schilddrüse : eine Matched-Pair Analyse |
Author(s): | Elwerr, Malik![]() |
Referee(s): | Lorenz, Kerstin![]() Rayes, Nada ![]() Holzer, Katharina |
Granting Institution: | Martin-Luther-Universität Halle-Wittenberg |
Issue Date: | 2020 |
Extent: | 1 Online-Ressource (64 Seiten) |
Type: | Hochschulschrift![]() |
Type: | PhDThesis |
Exam Date: | 2020-11-20 |
Language: | German |
URN: | urn:nbn:de:gbv:3:4-1981185920-358857 |
Abstract: | Calcitonin stimulation testing aims at defining the underlying type of c-cell disease (CCD) in order to customize appropriate timing and extent of surgery or consider observation. The importance of stimulation testing is widely accepted in hereditary CCD and the follow-up of MTC, while its role in sporadic forms is controversial. Importantly, calcium (Ca2+) stimulation testing lacks comparison to established recommendations based on reliable cut-off values using Pentagastrin (Pg). This study investigates the correlation of Ca2+- and Pg-stimulation testing in CCD. In a matched pair analysis, Pg- and Ca2+ -stimulation testing for calcitonin (Ct) was compared in 295 patients with c-cell hyperplasia (CCH) and with medullary thyroid cancer confined to the thyroid (Tx N0 M0) undergoing primary surgery. Calcitonin stimulation testing aims at defining the underlying type of c-cell disease (CCD) in order to customize appropriate timing and extent of surgery or consider observation. The importance of stimulation testing is widely accepted in hereditary CCD and the follow-up of MTC, while its role in sporadic forms is controversial. Importantly, calcium (Ca2+) stimulation testing lacks comparison to established recommendations based on reliable cut-off values using Pentagastrin (Pg). This study investigates the correlation of Ca2+- and Pg-stimulation testing in CCD. In a matched pair analysis, Pg- and Ca2+ -stimulation testing for calcitonin (Ct) was compared in 295 patients with c-cell hyperplasia (CCH) and with medullary thyroid cancer confined to the thyroid (Tx N0 M0) undergoing primary surgery. |
URI: | https://opendata.uni-halle.de//handle/1981185920/35885 http://dx.doi.org/10.25673/35667 |
Open Access: | ![]() |
License: | ![]() |
Appears in Collections: | Interne-Einreichungen |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Diss. Elwerr - Bibliothek-1.pdf | 1.42 MB | Adobe PDF | ![]() View/Open |